950260 - Ingenia Therapeutics Inc.(reg.s)

950260 Summary
Biopharma
Stock Price & Overview
₩15,580 -240 (-1.52%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩15,580  ≈ US$11  ·  Market cap ₩0.8tn (≈ $550m)

950260 Valuation vs Covered Peers

Metric950260Sector Medianvs Sector1Y Avgvs 1Y Avg
P/E (TTM)22.28x (24)
P/S (TTM)10.41x (46)
P/B5.23x (46)
P/CF (TTM)22.23x (27)
Sector median is the median of the 48 covered Biopharma names on kstock as of 2026-09-04 — not an index-wide figure. Averages cover the history shown below.

950260 Daily Valuation History

DateCloseMarket CapP/E (TTM)P/S (TTM)P/BP/CF (TTM)
2026-09-04₩15,580₩0.8tn
2026-09-03₩15,820₩0.8tn
2026-09-02₩17,250₩0.9tn
2026-09-01₩19,290₩1.0tn
2026-08-31₩17,640₩0.9tn
2026-08-28₩18,000₩0.9tn
2026-08-27₩17,350₩0.9tn
2026-08-26₩17,340₩0.9tn
2026-08-25₩16,560₩0.8tn
2026-08-24₩15,150₩0.7tn
2026-08-21₩15,770₩0.8tn
2026-08-20₩18,330₩0.9tn
2026-08-19₩14,100₩0.7tn
2026-08-18₩17,990₩0.9tn
Multiples use the close of each date against the financials that were publicly filed by that date (quarterly reports assumed available 45 days after quarter end; annual figures 90 days). Share count is today's — per-date share counts are not reconstructed, so market cap around buybacks or issuance is approximate. A dash means the trailing figure was negative or not reported — no value is imputed. Source: KRX closes, DART consolidated filings.

Similar to 950260

SymbolLast Price
185750Chong Kun Dang Pharmaceutical Corp.₩68,000
-0.3%
115180Qurient Co., Ltd.₩23,050
+17.3%
476830Rznomics, Inc.₩28,200
+6.8%
003850Boryung Corporation₩9,040
+1.6%
085660Chabiotech Co., Ltd.₩8,090
+2.1%
476060Onconic Therapeutics, Inc.₩16,440
-3.9%
041960Komipharm International Co., Ltd.₩9,710
+3.5%
317450Myungin Pharm₩44,650
+0.0%
001060JW Pharmaceutical₩27,500
+1.3%
456160G2GBIO, Inc.₩37,950
+5.7%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.